Advisor Resource Council Bristol Myers Squibb CO Transaction History

Advisor Resource Council

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$48.48 - $57.85 $591,213 - $705,480	12,195 New	12,195 $625,000
Q2 2022 Jul 27, 2022	BUY	$72.62 - $79.98 $1.2 Million - $1.32 Million	16,457 New	16,457 $1.27 Million
Q1 2022 Apr 20, 2022	SELL	$61.48 - $73.72 $331,315 - $397,277	-5,389 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $289,012 - $336,920	5,389 New	5,389 $336,000
Q3 2021 Nov 16, 2021	SELL	$59.17 - $69.31 $235,792 - $276,200	-3,985 Closed	0 $0
Q2 2021 Aug 19, 2021	BUY	$61.91 - $67.42 $230,243 - $250,734	3,719 Added 1398.12%	3,985 $266,000
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $16,468 - $17,933	266 New	266 $17,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Advisor Resource Council, based on Form 13F filings with the SEC.

Stay updated on Advisor Resource Council with notifications on news.